The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension
1 other identifier
interventional
30
1 country
1
Brief Summary
Refractory hypertension is defined as failure to reach goal blood pressure control in patients who are adherent to full doses of the appropriate drug regime. Hypertension results in 7.6 million deaths annually and 92 million disability adjusted years worldwide, making it the number one attributable risk for death throughout the world. Conventional treatment involves lifestyle modification and antihypertensive drug therapy; however blood pressure can remain uncontrolled despite these treatment options. Previous studies have demonstrated a reduction in blood pressure in adults with essential hypertension with the use of various homoeopathic complexes. There has been no research done to date on the effect of the homoeopathic combination of Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH in adults with refractory hypertension. The aim of the study is to investigate the effect of a homoeopathic complex Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH on blood pressure in adults with refractory hypertension, by means of blood pressure readings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Oct 2014
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 4, 2015
CompletedFirst Posted
Study publicly available on registry
April 17, 2015
CompletedMay 17, 2016
May 1, 2016
5 months
April 4, 2015
May 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weekly blood pressure measurements using a Dura Shock Handheld Aneroid sphygmomanometer model DS55
Blood pressure will be monitored in the left and right arm of each participant with a Dura Shock Handheld Aneroid sphygmomanometer model DS55, which will be correctly calibrated. An obese BP cuff will be used for overweight participants to ensure reliable results. Blood pressure measurements will be conducted according to standard operating procedures.
6 weeks
Study Arms (2)
20% Ethanol
PLACEBO COMPARATORTen drops of unmedicated 20% ethanol must be administered under the tongue, three times per day, thirty minutes before or after meals, for six weeks.
Homoeopathic complex
EXPERIMENTALTen drops of 20% ethanol medicated with Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH will be administered under the tongue, three times per day, thirty minutes before or after meals, for six weeks.
Interventions
20% ethanol medicated with Amylenum nitrosum 6cH, Crataegus oxyacantha 6cH, Natrium muriaticum 6cH and Scutellaria lateriflora 6cH.
Eligibility Criteria
You may qualify if:
- Are male or female, between the ages of 35-60 years;
- have a systolic blood pressure between 140 mmHg-160 mmHg;
- have a diastolic blood pressure between 90 mmHg-99 mmHg; and
- are on 3 or more conventional anti-hypertensive medications of different drug classes, one of which must be a diuretic.
You may not qualify if:
- Have a systolic blood pressure \< 140 mmHg; \> 160 mmHg;
- have a diastolic blood pressure \< 90 mmHg; \> 99 mmHg;
- are pregnant or lactating;
- are on any other herbal or homoeopathic medicine for the treatment of hypertension;
- have secondary organ damage from hypertension; and or
- suffer from chronic conditions such as severe cardiac disease, renal failure, malignant hypertension or diabetes mellitus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Johannesburg
Johannesburg, Gauteng, 2028, South Africa
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Janice Pellow, M.TechHom
University of Johannesburg
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr J. Pellow
Study Record Dates
First Submitted
April 4, 2015
First Posted
April 17, 2015
Study Start
October 1, 2014
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
May 17, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share